on September 12, 2005
Published online before print September 12, 2005, doi: 10.1161/CIRCULATIONAHA.105.535039
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 8, 2005
From the National Heart, Lung, and Blood Institute’s Framingham Heart Study (J.Ä., M.J.P., B.H.N., C.S.F., D.L., R.B.D., R.S.V.), National Heart, Lung, and Blood Institute, Bethesda, Md (C.S.F., D.L.); the Cardiology Section (R.S.V.), Preventive Medicine and Epidemiology (D.L., R.S.V.), Department of Medicine, Boston University School of Medicine, Boston, Mass; the Mathematics Department, Boston University, Boston, Mass (M.J.P., B.H.N., R.B.D.); Massachusetts General Hospital, Harvard Medical School, Boston, Mass (J.B.M.); and the Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden (J.Ä.). * To whom correspondence should be addressed. E-mail: vasan{at}bu.edu.
Background--The relations of insulin sensitivity (IS) to hypertension incidence may vary according to baseline age, body mass index (BMI), and blood pressure (BP). Methods and Results--We investigated the relations of IS (insulin sensitivity index, ISI0,120) to 4-year incidence of hypertension and BP progression in 1933 nonhypertensive Framingham Study participants (median age, 51 years; 56% women). Analyses were stratified by age (less than versus greater than or equal to median), BMI (<25 [normal], 25 to <30 [overweight], Conclusions--In our large community-based sample, reduced IS predicted BP tracking principally in younger people with normal BMI and BP<130/85 mm Hg. Effect modification by age, BMI, and baseline BP may explain variation in the results of prior clinical investigations relating IS to hypertension incidence.
Revised on May 28, 2005
Accepted on June 6, 2005
Relations of Insulin Sensitivity to Longitudinal Blood Pressure Tracking. Variations With Baseline Age, Body Mass Index, and Blood Pressure
Johan Ärnlöv MD, PhD,
30 kg/m2 [obese]), and BP category (systolic BP130 or diastolic BP85, "high normal" per the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High BP [JNC-VI] versus BP<130/85 mm Hg). On follow-up, 41% of participants had BP progression (1 BP stage increase) and 18% had development of hypertension (systolic BP140 or diastolic BP90 mm Hg or antihypertensive medication use). In younger (<51 years) people with normal BMI and baseline BP<130/85 mm Hg, the second-to-fourth ISI0,120 quartiles were associated with lower multivariable-adjusted odds for hypertension incidence (0.27; 95% CI, 0.09 to 0.83; P<0.05) and BP progression (0.37; 95% CI, 0.18 to 0.77; P<0.01) relative to the lowest (most insulin resistant) quartile. IS was not related to BP progression or hypertension incidence in older individuals, in obese participants, or in people with BP130/85 mm Hg.
Key words: blood pressure • epidemiology • hypertension • insulin • obesity
Related Article:
Circulation 2005 112: 1678-1680.
This article has been cited by other articles:
 |
|
 |
|
  J. P. Forman, H. Choi, and G. C. Curhan Uric Acid and Insulin Sensitivity and Risk of Incident Hypertension Arch Intern Med, January 26, 2009; 169(2): 155 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, L. H. Lindholm, B. Dahlof, and for the LIFE Study Investigators In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Hypertension, November 1, 2007; 50(5): 984 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. B. Hu and M. J. Stampfer Insulin Resistance and Hypertension: The Chicken-Egg Question Revisited Circulation, September 20, 2005; 112(12): 1678 - 1680. [Full Text] [PDF]
|
|